- Category
- Micro (2024-25)
- Udyam number
- UDYAM-BR-37-0019731

Basdils Pharmaceuticals Private Limited
About Basdils Pharmaceuticals Private Limited
Data last updated:
Basdils Pharmaceuticals Private Limited is a private limited company based in Hajipur, Bihar, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 20 January 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U51909BR2017PTC033368. Its GSTIN is 10AAHCB0874B1ZD (Bihar).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors Basant Kumar Singh (Managing Director) and Dilasa Kumari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O – Dilasa Kumari W/O – Dr. Basant Kumar Singh Bagmali Bari Jagdamba Asthan, Hajipur, Bihar, India – 844101.
As per the financials filed for FY 2024, the company reported a revenue of ₹10 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹21,494 (net margin -2.1%) and EBITDA of -₹15,320 (EBITDA margin -1.5%).
Basdils Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-BR-37-0019731). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Basdils Pharmaceuticals
Contact details
Basdils Pharmaceuticals Private Limited's registered office is in Hajipur, Bihar. Its e-mail address is in the company report.
- Email
- Registered AddressC/O – Dilasa Kumari W/O – Dr. Basant Kumar Singh Bagmali Bari Jagdamba Asthan, Hajipur, Bihar, India – 844101
- IndustryTrading, Specialty, Wholesale
To see the full contact details of Basdils Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Basdils Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Basdils Pharmaceuticals Private Limited, buy the company report.
Financials of Basdils Pharmaceuticals Private Limited
FY 2025 filings availableBasdils Pharmaceuticals Private Limited reported revenue of ₹10 Lakh (up 2098% YoY) for FY 2024.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹15,320 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹21,494 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -1.5% | ||||
| Net Profit Margin | -2.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Basdils Pharmaceuticals Private Limited, buy the company report.
Board of directors of Basdils Pharmaceuticals Private Limited
Basdils Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Basant Kumar Singh | Managing Director | 20 Jan 2017 | 9 Years 9 Months | Current |
| Dilasa Kumari | Director | 20 Jan 2017 | 9 Years 9 Months | Current |
Peer comparison
Basdils Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Pragyay Pharmaceuticals Private Limited | ₹10.14 Lakh (FY 2024) | 21.0% | Faizabad, Uttar Pradesh, India | |||
| Amitex Pharmaceuticals Private Limited | ₹10.07 Lakh (FY 2025) | 10.0% | Lucknow, Uttar Pradesh, India | |||
| Ny Med Pharmaceuticals Private Limited | ₹10.04 Lakh (FY 2024) | 440.0% | Delhi, India | |||
| Basdils Pharmaceuticals Private Limitedthis company | ₹10 Lakh (FY 2024) | -₹21,494 | -2.1% | 2098.0% | Hajipur, Bihar, India | |
| Catkin Pharmaceuticals Private Limited | ₹9.96 Lakh (FY 2025) | -16.0% | Dehradun, Uttarakhand, India |
To see the full peer comparison of Basdils Pharmaceuticals Private Limited, buy the company report.
Auditor
Basdils Pharmaceuticals Private Limited is audited by SHRAWAN KUMAR AND ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SHRAWAN KUMAR AND ASSOCIATES | FY 2017 | 413548 |
Shareholding
The shareholding of Basdils Pharmaceuticals Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Basdils Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Basdils Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Basdils Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Basdils Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAHCB0874B1ZD | Bihar | Active | 02 Feb 2020 |
To see the full GST registrations and return filing status of Basdils Pharmaceuticals Private Limited, buy the company report.
Recent activity
Basdils Pharmaceuticals Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Basant Kumar Singh was appointed as Managing Director on 20 Jan 2017.
Frequently asked questions
Basdils Pharmaceuticals is an active private limited company based in Hajipur, Bihar, India. The company works in specialty, within the trading industry. It was incorporated on 20 January 2017 (9+ years old) and is registered under CIN U51909BR2017PTC033368.
Basdils Pharmaceuticals has 2 current directors:
- Basant Kumar Singh - Managing Director
- Dilasa Kumari - Director
The latest financial statements of Basdils Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Basdils Pharmaceuticals is 10AAHCB0874B1ZD, registered in Bihar.
The CIN (Corporate Identification Number) of Basdils Pharmaceuticals is U51909BR2017PTC033368. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Basdils Pharmaceuticals was incorporated on 20 January 2017, making it 9+ years old. It is registered with the Registrar of Companies, Patna.
The peers of Basdils Pharmaceuticals by revenue are Pragyay Pharmaceuticals Private Limited, Amitex Pharmaceuticals Private Limited, Ny Med Pharmaceuticals Private Limited, Catkin Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Basant Kumar Singh was appointed as Managing Director on 20 Jan 2017. Dilasa Kumari was appointed as Director on 20 Jan 2017.
Yes, Basdils Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-BR-37-0019731).
The registered office of Basdils Pharmaceuticals is at CO – Dilasa Kumari WO – Dr. Basant Kumar Singh Bagmali Bari Jagdamba Asthan, Hajipur, Bihar, India – 844101.
Basdils Pharmaceuticals operates in the trading industry, in the specialty segment.